| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
MK 3207 hydrochloride
|
957116-20-0 |
(8R)-8-(3,5-二氟苯基)-10-氧代-N-[(2R)-1,1',2',3-四氢-2'-氧代螺[2H-茚-2,3'-[3H]吡咯并[2,3-B]吡啶]-5-基]-6,9-二氮杂螺[4.5]癸烷-9-乙酰胺盐酸盐
|
(8R)-8-(3,5-二氟苯基)-10-氧代-N-[(2R)-1,1',2',3-四氢-2'-氧代螺[2H-茚-2,3'-[3H]吡咯并[2,3-B]吡啶]-5-基]-6,9-二氮杂螺[4.5]癸烷-9-乙酰胺盐酸盐;MK3207 HYDROCHLORIDE;MK 3207 HYDROCHLORIDE;MK-3207;MK 3207 盐酸盐
|
C31H29N5O3F2.HCl |
594.0514 | 200-258-5 |
|
AG-1478 (Tyrphostin AG-1478)
|
153436-53-4 |
AG1478
|
4-(3-氯苯胺)-6,7-二甲氧基喹唑啉盐酸盐;AG1478;TYRPHOSTIN AG1478;AG 1478;NSC 693255;AG1478;TYRPHOSTIN AG1478;AG 1478;AG-1478>98%;酪氨酸激酶抑制剂AG 1478;AG-1478,一种选择性EGFR抑制剂;(3-氯苯基)(6,7-二甲氧基喹唑啉-4-基)胺;4-(3-氯苯胺)-6,7-二甲氧基喹唑啉盐酸盐
|
C16H14N3O2Cl |
315.75426 | |
|
PU-H71
|
873436-91-0 |
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-异丙基-9H-嘌呤-9-丙胺
|
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-异丙基-9H-嘌呤-9-丙胺;CS-105
|
C18H21IN6O2S |
||
|
(R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
|
1985607-70-2 |
(R)-7-苄氧基-3,4,12,12A-四氢-1H-[1,4]联氮[3,4-C]吡啶并[2,1-F][1,2,4]三嗪-6,8-二酮
|
巴洛沙韦杂质3;(R)-7-(苄氧基)-3,4,12,12A-四氢-1H-[1,4]噁嗪[3,4-C]吡啶并[2,1-F] [1,2,4]三嗪-6,8二酮(巴沙洛韦母核);(R)-7-苄氧基-3,4]联氮[3,1-F][1,8-二酮;(R)-7-(苄氧基)-3,8-二酮;
(12aR)-3,12a-四氢-7-(苯基甲氧基)-1H-[1,4]恶嗪基[3,4-c]吡啶基[2,8-二酮;(12AR)-3,12A-四氢-7-(苯基甲氧基)-1H-[1,4]恶嗪并[3,8-二酮;CS-2819
|
C17H17N3O4 |
327.33 | |
|
Letermovir
|
917389-32-3 |
LETERMOVIR
|
CS-2799;乐特莫韦;AIC246;AIC 246;AIC-246
|
C29H28F4N4O4 |
572.5506328 | |
|
BALOXAVIR MARBOXIL
|
1985606-14-1 |
巴洛沙韦酯
|
巴洛沙韦的杂质对照品;巴沙洛韦酯;巴洛沙韦杂质;巴洛沙韦酯;巴洛莎韦
|
C27H23F2N3O7S |
571.6 | |
|
AM966
|
1228690-19-4 |
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
|
(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid;AM 966;4'-[4-[[[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid
|
C27H23ClN2O5 |
490.9407 | |
|
Protein degrader 1 hydrochloride
|
1448189-80-7 |
ULM-1
|
MDK-7526;ULM-1;CS-2718;(S,R,S)-AHPC盐酸盐;(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐;PROTEIN DEGRADER 1 HYDROCHLORIDE;MDK7526 HCL;MDK7526;MDK-7526;MDK 7526;VHL LIGAND 1;ULM-1;VH032 DESACETYL HYDROCHLORIDE;VH032 AMINE HCL;DEGRADATION INDUCING MOIETY A;
|
C22H31ClN4O3S |
467.02454 | |
|
CHR2797 (Tosedostat)
|
238750-77-1 |
托舍多特
|
ALPHA-[[(2R)-2-[(1S)-1-羟基-2-(羟基氨基)-2-氧代乙基]-4-甲基-1-氧代戊基]氨基]苯乙酸环戊酯;托舍多特
|
C21H30N2O6 |
406.47 | 200-258-5 |
|
ALW-II-41-27
|
1186206-79-0 |
ALW-II-41-27
|
CS-2709
|
C32H32F3N5O2S |
607.68899 | |
|
PF9-366
|
72882-78-1 |
CS-2703
|
PF-9366;PF 9366;PF9366;72882-78-1;CS-2703
|
C20H19ClN4 |
350.84466 | |
|
SC75741
|
913822-46-5 |
SC75741
|
N-(6-苯甲酰基-1H-苯并咪唑-2-基)-2-(1-噻吩并[3,2-D]嘧啶-4-基-4-哌啶基)-4-噻唑甲酰胺;CS-2697
|
C29H25N7O2S2 |
567.6845 | |
|
SR-4370
|
1816294-67-3 |
SR-4370
|
SR-4370;SR 4370;SR4370;CS-2695
|
C17H18F2N2O |
||
|
Nosiheptide
|
56377-79-8 |
那西肽
|
诺西肽;诺西肽;CS-2680;诺西肽;诺肽菌素;那西肽;那西肽1%预混粉;那西肽91%
|
C51H43N13O12S6 |
1222.35702 | 260-138-4 |
|
6-OAU
|
83797-69-7 |
GTPL5846
|
GTPL5846>98%;CS-2658;GTPL 5846;GTPL5846;6-OAU;GTPL-5846;GTPL5846;6-(辛基氨基)-2,4(1H,3H)-嘧啶二酮
|
C12H21N3O2 |
239.31404 | |
|
AZD3839
|
1227163-84-9 |
AZD3839
|
AZD3839富马酸盐;AZD3839;AZD-3839;AZD 3839;CS-2630
|
C24H16F3N5 |
431.41255 | 682-619-1 |
|
Esaxerenone
|
1632006-28-0 |
CS-2614
|
|
C22H21F3N2O4S |
466.475 | |
|
SD-06
|
271576-80-8 |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
|
SD 0006;3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑;SD-06;SD 06;SD06;CS-2591
|
C20H20ClN5O2 |
397.8581 | |
|
Dasotraline hydrochloride
|
675126-08-6 |
达索曲林盐酸盐
|
达索曲林盐酸盐;SEP-225289;DSP-225289;DASTROLINE
|
C16H15Cl2N.ClH |
328.668 | |
|
4-(2-Aminoethyl)benzenesulfonylfluoride hydrochloride
|
30827-99-7 |
4-(2-氨乙基)苯磺酰氟盐酸盐
|
AEBSF(进分);4-(2-氨乙基)苯磺酰氟酸盐;4-(2-氨乙基)苯磺酰氟盐酸盐;4-2-胺乙基苯磺酰氟盐酸盐;4-(2-氨乙基)苯磺酰氟盐酸盐,97%;4-(2-氨基乙基)氟苯磺酰盐酸盐;4-(2-氨乙基)苯磺酰氟盐酸盐(AEBSF)
|
C8H11ClFNO2S |
239.69484 | 608-547-2 |
药智官方微信
药智官方微博
